{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:48:55Z","timestamp":1757623735362,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.rcsop.2021.100101","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T12:33:53Z","timestamp":1640781233000},"page":"100101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of Pakistan"],"prefix":"10.1016","volume":"5","author":[{"given":"Zia Ul","family":"Mustafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia Siang","family":"Kow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahpara","family":"Kanwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Bilal","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samina","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Shahzad","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2021.100101_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.rcsop.2021.100101_bb0010","article-title":"Could it be that the B.1.1.7 lineage is more deadly? [published online ahead of print, 2021 Feb 9]","volume":"1","author":"Kow","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100101_bb0015","first-page":"e14","article-title":"Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK [published online ahead of print, 2021 may 13]","volume":"83","author":"Kow","year":"2021","journal-title":"J Inf Secur"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100101_bb0020","doi-asserted-by":"crossref","first-page":"668","DOI":"10.14336\/AD.2020.0502","article-title":"Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and Meta-analysis","volume":"11","author":"Liu","year":"2020","journal-title":"Aging Dis"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100101_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13613-021-00820-w","article-title":"Intensive care management of patients with COVID-19: a practical approach","volume":"11","author":"Hajjar","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"6","key":"10.1016\/j.rcsop.2021.100101_bb0030","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s43440-020-00155-6","article-title":"Drug repurposing approach to fight COVID-19","volume":"72","author":"Singh","year":"2020","journal-title":"Pharmacol Rep"},{"author":"Ministry of National Health Services, Regulations & Coordination, Government of Pakistan","key":"10.1016\/j.rcsop.2021.100101_bb0035"},{"issue":"8","key":"10.1016\/j.rcsop.2021.100101_bb0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.rcsop.2021.100101_bb0045","doi-asserted-by":"crossref","first-page":"e2848","DOI":"10.1093\/cid\/ciaa1423","article-title":"Corticosteroid-related in-hospital hyperglycemia: does it negate mortality benefits in COVID-19? [published online ahead of print, 2020 Sep 18]","volume":"73","author":"Kow","year":"2021","journal-title":"Clin Infect Dis."},{"issue":"5","key":"10.1016\/j.rcsop.2021.100101_bb0050","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.4269\/ajtmh.20-1059a","article-title":"Concurrent antibiotic therapy in disseminated strongyloidiasis","volume":"103","author":"Kow","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"10303","key":"10.1016\/j.rcsop.2021.100101_bb0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","article-title":"Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial [published correction appears in Lancet","volume":"398","author":"Yu","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.rcsop.2021.100101_bb0060","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial [published online ahead of print, 2021 Apr 9] [published correction appears in Lancet Respir Med. 2021 Jun;9(6):e55]","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.rcsop.2021.100101_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.rcsop.2021.100101_bb0070","first-page":"1","article-title":"The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis [published online ahead of print, 2021 Mar 29]","author":"Kow","year":"2021","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.rcsop.2021.100101_bb0075","article-title":"Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial","author":"Niaee","year":"2020","journal-title":"Preprint Research Square"},{"year":"2020","series-title":"Efficacy and safety of Ivermectin for treatment and prophylaxis of COVID-19 pandemic","author":"Elgazzar","key":"10.1016\/j.rcsop.2021.100101_bb0080"},{"issue":"4","key":"10.1016\/j.rcsop.2021.100101_bb0085","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/jmv.26638","article-title":"Effect of remdesivir on mortality in patients with COVID-19: a meta-analysis of randomized control trials","volume":"93","author":"Kow","year":"2021","journal-title":"J Med Virol"},{"issue":"19","key":"10.1016\/j.rcsop.2021.100101_bb0090","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.rcsop.2021.100101_bb0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results","volume":"384","author":"WHO Solidarity Trial Consortium","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100101_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmi.2020.09.041","article-title":"Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline","volume":"27","author":"Sieswerda","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.rcsop.2021.100101_bb0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.rcsop.2021.100101_bb0110","first-page":"1","article-title":"Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan [published online ahead of print, 2021 May 28]","author":"Ul Mustafa","year":"2021","journal-title":"SN Compr Clin Med"},{"key":"10.1016\/j.rcsop.2021.100101_bb0115","article-title":"Efficacy and safety of azithromycin in Covid-19 patients: a systematic review and meta-analysis of randomized clinical trials [published online ahead of print, 2021 Jun 2]","author":"Kamel","year":"2021","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.rcsop.2021.100101_bb0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/cid\/ciu236","article-title":"Fluoroquinolone use is a risk factor for methicillin-resistant Staphylococcus aureus acquisition in long-term care facilities: a nested case-case-control study","volume":"59","author":"Couderc","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.rcsop.2021.100101_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2710.2007.00836.x","article-title":"Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains","volume":"32","author":"Urb\u00e1nek","year":"2007","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"10.1016\/j.rcsop.2021.100101_bb0130","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19","volume":"385","author":"REMAP-CAP Investigators","year":"2021","journal-title":"N Engl J Med."},{"issue":"9","key":"10.1016\/j.rcsop.2021.100101_bb0135","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19","volume":"385","author":"ATTACC Investigators","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rcsop.2021.100101_bib161","unstructured":"Kow CS, Ramachandram DS, Hasan SS. The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials [published online ahead of print, 2021 Nov 17]. J Infect Chemother. 2021;S1341-321X(21)00319-6."},{"issue":"21","key":"10.1016\/j.rcsop.2021.100101_bb0140","first-page":"01203","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"S0140-6736","author":"Lopes","year":"2021","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.rcsop.2021.100101_bb0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jvsv.2020.06.006","article-title":"Use of low-molecular-weight heparin in COVID-19 patients","volume":"8","author":"Kow","year":"2020","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"1","key":"10.1016\/j.rcsop.2021.100101_bb0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/joim.13183","article-title":"Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis","volume":"289","author":"Kow","year":"2021","journal-title":"J Intern Med"},{"issue":"13","key":"10.1016\/j.rcsop.2021.100101_bb0155","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.rcsop.2021.100101_bb0160","doi-asserted-by":"crossref","first-page":"2002808","DOI":"10.1183\/13993003.02808-2020","article-title":"Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial","volume":"56","author":"Edalatifard","year":"2020","journal-title":"Eur Respir J"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276621001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276621001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:28:00Z","timestamp":1757406480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276621001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":33,"alternative-id":["S2667276621001013"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2021.100101","relation":{},"ISSN":["2667-2766"],"issn-type":[{"type":"print","value":"2667-2766"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of Pakistan","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2021.100101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100101"}}